58-17b-625. Administration of a long-acting injectable and naloxone.
172 words·~1 min read·
/ut/title-58/chapter-17b/58-17b-625A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 10/1/2024
58-17b-625. Administration of a long-acting injectable and naloxone.
(1)A pharmacist may, in accordance with this section, administer a drug described in Subsection (2).
(2)Notwithstanding the provisions of Subsection 58-17b-102 (58)(c)(ii)(B), the division shall make rules in collaboration with the board and, when appropriate, the Medical Licensing Board created in Section 58-67-201 , and in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish training for a pharmacist to administer naloxone and long-acting injectables intramuscularly.
(3)A pharmacist may not administer naloxone or a long-acting injectable intramuscularly unless the pharmacist:
(a)completes the training described in Subsection (2);
(b)administers the drug at a clinic or community pharmacy, as those terms are defined by the division, by administrative rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act; and
(c)is directed by the physician, as that term is defined in Section 58-67-102 or Section 58-68-102 , who issues the prescription to administer the drug.
Amended by Chapter 507 , 2024 General Session